Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 3 |
2021 | 3 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Single-center retrospective study assessing the efficacy and safety of BeEAM (bendamustine, etoposide, cytarabine, melphalan) as conditioning regimen for autologous hematopoietic stem cell transplantation.
Leuk Lymphoma. 2023 Jul-Aug;64(7):1234-1242. doi: 10.1080/10428194.2023.2203790. Epub 2023 May 8.
Leuk Lymphoma. 2023.
PMID: 37154396
Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study.
LeBlanc R, Ahmad I, Terra R, Boudreault JS, Ogez D, Lamore K, Delisle JS, Bambace N, Bernard L, Cohen S, Kiss T, Lachance S, Landais S, Lemieux-Blanchard É, Sauvageau G, Sebag M, Roy DC, Roy J.
LeBlanc R, et al. Among authors: boudreault js.
Bone Marrow Transplant. 2022 Feb;57(2):252-260. doi: 10.1038/s41409-021-01532-2. Epub 2021 Nov 29.
Bone Marrow Transplant. 2022.
PMID: 34845367
Clinical Trial.
Item in Clipboard
Testing Mayo Clinic's New 20/20/20 Risk Model in Another Cohort of Smoldering Myeloma Patients: A Retrospective Study.
Tessier C, Allard T, Boudreault JS, Kaedbey R, Éthier V, Fortin F, Pavic M.
Tessier C, et al. Among authors: boudreault js.
Curr Oncol. 2021 May 26;28(3):2029-2039. doi: 10.3390/curroncol28030188.
Curr Oncol. 2021.
PMID: 34073289
Free PMC article.
Item in Clipboard
Bendamustine-induced nephrogenic diabetes insipidus - A case report.
Desjardins A, Le-Nguyen V, Turgeon-Mallette L, Vo C, Boudreault JS, Rioux JP, Feng X, Veilleux A.
Desjardins A, et al. Among authors: boudreault js.
J Oncol Pharm Pract. 2022 Jan;28(1):205-210. doi: 10.1177/10781552211013878. Epub 2021 May 14.
J Oncol Pharm Pract. 2022.
PMID: 33990157
Free PMC article.
Item in Clipboard
Triplet combinations in relapsed/refractory myeloma: update on recent phase 3 trials.
Boudreault JS, Touzeau C, Moreau P.
Boudreault JS, et al.
Expert Rev Hematol. 2017 Mar;10(3):207-215. doi: 10.1080/17474086.2017.1285694. Epub 2017 Feb 9.
Expert Rev Hematol. 2017.
PMID: 28110581
Review.
Item in Clipboard
Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14).
Touzeau C, Le Gouill S, Mahé B, Boudreault JS, Gastinne T, Blin N, Caillon H, Dousset C, Amiot M, Moreau P.
Touzeau C, et al. Among authors: boudreault js.
Haematologica. 2017 Mar;102(3):e112-e114. doi: 10.3324/haematol.2016.160408. Epub 2017 Jan 5.
Haematologica. 2017.
PMID: 28057737
Free PMC article.
No abstract available.
Item in Clipboard
The role of SLAMF7 in multiple myeloma: impact on therapy.
Boudreault JS, Touzeau C, Moreau P.
Boudreault JS, et al.
Expert Rev Clin Immunol. 2017 Jan;13(1):67-75. doi: 10.1080/1744666X.2016.1209112. Epub 2016 Jul 18.
Expert Rev Clin Immunol. 2017.
PMID: 27376202
Review.
Item in Clipboard
Cite
Cite